Premium
Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function
Author(s) -
Fasshauer M.,
Blüher M.,
Stumvoll M.,
Tönessen P.,
Faber R.,
Stepan H.
Publication year - 2007
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/j.1365-2265.2007.02751.x
Subject(s) - adiponectin , adipokine , medicine , endocrinology , insulin resistance , pregnancy , intrauterine growth restriction , insulin , fetus , biology , genetics
Summary Objective There is compelling evidence that insulin resistance may play a pivotal role in the development of pregnancy complications including pre‐eclampsia and intrauterine growth restriction (IUGR). As dysregulation of visfatin and adiponectin is found in insulin resistance, both adipokines might contribute to pregnancy disorders. Patients and methods Plasma levels of visfatin and adiponectin were quantified in second‐trimester pregnancies with abnormal uterine perfusion and in third‐trimester pregnancies with IUGR as compared to healthy controls. Results Mean plasma adiponectin levels were significantly increased in women with pathological perfusion (7078 ± 789 ng/ml) as compared to normal uterine perfusion (4481 ± 1183 ng/ml) ( P < 0·05) whereas visfatin plasma concentrations were not different between these groups. Visfatin levels were significantly elevated in women with IUGR (140·1 ± 10 ng/ml) as compared to patients with normal outcome (65·5 ± 11 ng/ml) ( P < 0·05). By contrast, adiponectin plasma concentrations were not significantly altered in women with IUGR. Conclusions Our data support the view that the adipokines visfatin and adiponectin are differentially regulated in pregnancy complications.